Eiichi Suematsu Selected Research

Methotrexate (Mexate)

1/2017	Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.
12/2015	Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.
7/2015	Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
9/2014	Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.
4/2013	Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.
3/2013	Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate.
8/2010	Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eiichi Suematsu Research Topics

Disease

21	Rheumatoid Arthritis 04/2022 - 04/2008
9	Infections 01/2017 - 09/2006
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 04/2008
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2013
4	Systemic Scleroderma (Systemic Sclerosis) 11/2020 - 12/2002
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016 - 02/2003
3	Vasculitis (Vasculitides) 01/2016 - 12/2002
2	Rheumatic Diseases (Rheumatism) 04/2018 - 06/2015
2	Neoplasms (Cancer) 01/2016 - 09/2006
2	Takayasu Arteritis (Arteritis, Takayasu's) 01/2015 - 01/2011
2	Arthritis (Polyarthritis) 01/2010 - 04/2009
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2010 - 04/2008
2	Thrombocytopenia (Thrombopenia) 04/2009 - 01/2009
1	Diverticulum 04/2022
1	Mixed Connective Tissue Disease (MCTD) 01/2022
1	Lung Diseases (Lung Disease) 01/2017
1	Diabetes Mellitus 01/2017
1	Bronchiectasis 11/2016
1	Behcet Syndrome (Behcet's Syndrome) 01/2016
1	Necrosis 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2015
1	Polymyositis 01/2015
1	Arteritis 01/2015
1	Autoimmune Hepatitis 01/2015
1	Epstein-Barr Virus Infections 04/2013
1	Psychotic Disorders (Schizoaffective Disorder) 01/2013
1	Osteonecrosis (Kienbock's Disease) 01/2013
1	Adult-Onset Still's Disease 01/2012
1	Lung Neoplasms (Lung Cancer) 10/2011
1	Relapsing Polychondritis 10/2011
1	HIV Infections (HIV Infection) 04/2011
1	Lipodystrophy 04/2011
1	Churg-Strauss Syndrome (Allergic Angiitis) 02/2011
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 01/2011
1	Ulcerative Colitis 01/2011
1	Graves Disease (Basedow Disease) 01/2011
1	Proteinuria 08/2010

Drug/Important Bio-Agent (IBA)

7	tocilizumab (atlizumab)FDA Link 04/2022 - 08/2010
7	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 08/2010
5	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 06/2006
4	Abatacept (Orencia)FDA Link 01/2017 - 03/2013
4	Rituximab (Mabthera)FDA Link 07/2015 - 04/2007
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2010 - 12/2002
3	Biological ProductsIBA 04/2018 - 09/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 04/2007
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 01/2011
3	SteroidsIBA 01/2016 - 04/2010
3	Polysaccharides (Glycans)IBA 12/2015 - 06/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2014 - 04/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 04/2005
2	AntibodiesIBA 01/2022 - 01/2015
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2013
2	RibonucleoproteinsIBA 01/2022 - 01/2013
2	Etanercept (Enbrel)FDA Link 01/2017 - 01/2010
2	Infliximab (Remicade)FDA Link 01/2017 - 01/2016
2	Adalimumab (Humira)FDA Link 01/2017 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2016 - 01/2013
2	Methylprednisolone FDA LinkGeneric 01/2016 - 04/2007
2	23-valent pneumococcal capsular polysaccharide vaccineIBA 12/2015 - 06/2015
2	GlucocorticoidsIBA 01/2013 - 01/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2010 - 12/2002
2	thiamine triphosphorate (TTP)IBA 04/2009 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 04/2009 - 01/2009
1	HLA-DRB1*04:01 antigenIBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 11/2020
1	sifalimumabIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	InterferonsIBA 01/2020
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 04/2018
1	tofacitinibIBA 01/2017
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Azathioprine (Imuran)FDA LinkGeneric 01/2016
1	HLA-G Antigens (HLA G)IBA 01/2016
1	VaccinesIBA 12/2015
1	golimumab FDA Link 12/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2015
1	Antirheumatic Agents (DMARD)IBA 09/2014
1	HLA-DR6 Antigen (HLA DR6 Antigen)IBA 01/2014
1	Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA 01/2014
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2013
1	SS-B antibodiesIBA 01/2013
1	AutoantibodiesIBA 01/2013
1	Interleukin-18 (Interleukin 18)IBA 01/2012
1	InterleukinsIBA 01/2012
1	Immunoglobulins (Immunoglobulin)IBA 10/2011
1	Immunoglobulin G (IgG)IBA 10/2011
1	Interleukin-5 (Interleukin 5)IBA 02/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2011
1	Phenobarbital (Luminal)FDA Link 01/2011
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2011
1	NitrogenIBA 08/2010

Therapy/Procedure

10	Therapeutics 01/2016 - 02/2002
1	Traction 11/2016